SEC Form SC 13G/A filed by Sorrento Therapeutics Inc. (Amendment)
$SRNE
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/2/2022 | $5.00 | Overweight | Cantor Fitzgerald |
8/9/2021 | $30.00 → $26.00 | Buy | HC Wainwright & Co. |